Not exact matches
A similar virus, called H101, is already marketed in China to
treat head and
neck cancers.
Yang et al. report on one such strategy: Taking the knowledge that an increase in type I interferons (IFNs) correlates positively with clinical outcome in several
cancers and that type I IFNs can enhance antitumor immunity in some models, the authors tethered IFN - β to a monoclonal antibody targeting the epithelial growth factor receptor (EGFR), which is approved for use in
treating metastatic colorectal
cancer and head and
neck cancer.
Silent Stories explores the strength of
cancer patients who underwent radiotherapy to
treat head or
neck cancer.
The two facilities using proton therapy most commonly
treated CNS and head and
neck cancers.
2003 Chinese company Shenzhen SiBiono GeneTech gains approval for
treating head and
neck cancer with Gendicine, a modified adenovirus carrying a tumour - suppressor gene.
Dr. Bauman and her colleagues
treated human head and
neck cancer cells in the laboratory with varying doses of sulforaphane and a control, and compared them to normal, healthy cells that line the throat and mouth.
The VA - UAB team says, based on its lab studies, that honokiol binds more strongly with EGFR than does the drug gefitinib (sold as Iressa), which is commonly used to
treat head and
neck cancers.
«This study, one of only a few large studies to have follow - up beyond five years, demonstrates that patients who have head and
neck cancers and who are being
treated with radiation therapy alone have improved local - regional control and no increase in late toxicity when radiation therapy is delivered twice a day in two smaller doses which we call hyperfractionation,» said Jonathan J. Beitler, MD, MBA, FASTRO, lead author of the study and professor of radiation oncology, otolaryngology and hematology / medical oncology at the Winship
Cancer Institute of Emory University School of Medicine in Atlanta.
They discovered that people with both head and
neck squamous cell carcinoma and the KRAS - variant who were
treated with standard treatment, but not with cetuximab, had a higher risk of failing treatment and developing metastatic disease, meaning the
cancer spreads to distant organs and is incurable.
Patients with head and
neck cancer seldom survive for longer than six months to one year when
treated with chemotherapy alone.
THREE patients with incurable
neck and head
cancer have survived for three years after being
treated with a combination of chemotherapy and a cold virus that has been modified to attack tumours.
Pembrolizumab, in particular, has been used to
treat melanoma, non-small cell lung
cancer, and in some cases, head and
neck cancers.
In addition to these
cancers, City of Hope's head and
neck cancer team also
treats thyroid
cancer, skin
cancers and sarcomas in the head and
neck region.
Our multidisciplinary staff pursues an integrated approach to
treating head and
neck cancers by combining the latest research findings with outstanding patient care.
Our physicians have been consistently named «America's Top Doctors» by Castle Connolly and are active participants in the National Comprehensive
Cancer Network, which sets evidence - based best practices for detecting, evaluating and
treating head and
neck cancers nationwide.
Immunotherapy using checkpoint inhibitors has changed the way we
treat several aggressive
cancers such as melanoma, non-small cell lung and head &
neck cancers, among others, with durable responses achieved in the metastatic setting.
In a recent multi-institutional phase II trial of Onyx - 015 led by investigators at University of Texas M.D. Anderson
Cancer Center, 30 patients with advanced head and neck cancer, most of whom had failed surgery or radiation therapy, were tr
Cancer Center, 30 patients with advanced head and
neck cancer, most of whom had failed surgery or radiation therapy, were tr
cancer, most of whom had failed surgery or radiation therapy, were
treated.
Scientists reported Tuesday on two new studies showing that the medications, which marshal the body's own immune defenses, are now having some effect against recurrent, difficult - to -
treat head and
neck cancer and an extremely lethal skin
cancer called Merkel cell carcinoma.
This revolutionary, FDA - approved treatment has been successful in
treating head - and -
neck and prostate
cancers.
The researchers
treated 76 patients between 1993 and 1996 with intensive therapy for advanced
cancers of the head and
neck.
More advanced head and
neck cancers are generally
treated with multi-modality surgery, including various combinations of surgery, radiation, and chemotherapy.
In collaboration with colleague Uli Rodeck, Williams also applied this insight to significantly improve the affinity of cetuximab, an anti-EGFR antibody used to
treat colorectal and head - and -
neck cancers.
During the study, the researchers tracked the pre-and-post treatment diets and ultimate health outcomes of more than 400
cancer patients for an average of 26 months after they were first diagnosed and
treated for squamous - cell carcinoma of the head or
neck.
As a surgeon who
treats patients with head and
neck cancer, Kim approaches research from a translational standpoint to understand the relationship between neoplastic transformation and the host immune response.
UT Southwestern's team of head and
neck cancer specialists
treats only head and
neck cancer, giving us a level of expertise that is on par with top U.S.
cancer programs.
«Because [IMRT] has been shown to reduce toxicity, it has been accepted to
treat prostate, brain, and head and
neck cancers,» said Chun, who was from The University of Texas MD Anderson
Cancer Center.
This
cancer often spreads quickly into the
neck and to other parts of the body, and is very hard to
treat.
Even
cancers that have reached stage IV (the most advanced stage, which means tumors have spread to other parts of the throat,
neck, or lymph nodes) can often be successfully
treated.
The patient in the Annals of Oncology report, «Mr. S» (the authors don't use his name because of confidentiality concerns), had been
treated for advanced head and
neck cancer.
Taxotere is a chemotherapy drug that
treats patients by killing
cancer cells, especially those of the breast, lungs, stomach, prostate,
neck, and head.
ENTA has a clinical alliance with The Mount Sinai Hospital for the treatment of diseases of the head and
neck and esophageal
cancer and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and c
cancer and a partnership with the American
Cancer Society to educate and treat patients with smoking disorders and c
Cancer Society to educate and
treat patients with smoking disorders and
cancercancer.